Discover and read the best of Twitter Threads about #DivisLaboratories

Most recents (2)

#DivisLaboratories Q3 FY22 concall highlights 💊💊

Like & retweet for better reach !

1. Revenues for the quarter stood at ₹2510 Cr (46% growth YoY).

2. PBT for the quarter stood at ₹1034 Cr (61% growth YoY).
3. Exports contributed to 92% of revenues for the quarter. Europe and the US contributed to 79% of revenues .

4. Generics contributed to 40% and Custom Synthesis contributed to 60% of revenues for the quarter. Nutraceutical business contributed ₹166 Cr for the quarter.
5. They have capitalized ₹196 Cr of capex during the quarter and ₹762 Cr for 9 months. They expect another ₹100 Cr to be capitalized by the end of the financial year. Capex in the new SEZ accounted for ₹368 Cr.
Read 13 tweets
#MCProOpinion | Divi’s is well placed to benefit from increased sourcing by global innovators seeking to lower dependence on China. But risks exist, writes R Sree Ram

#DivisLaboratories #Markets
moneycontrol.com/news/opinion/h…
#MCProOpinion | There has been much talk about mitigating the impact of climate change at the macro level. The concerns are now percolating down to its impact on companies: Sundeep Khanna (@companyoutsider)

#ClimateChange #ClimateAction
moneycontrol.com/news/opinion/c…
What could spoil the party in the markets? The return of inflation is one risk that many are flagging, Manas Chakravarty writes for #MCProOpinion

#Inflation #Markets #Economy
moneycontrol.com/news/opinion/c…
Read 4 tweets

Related hashtags

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3.00/month or $30.00/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!